Union Budget: Pharma shares rise 
Union Budget: Pharma shares rise Pharma shares were trading higher on Sunday after Finance Minister Nirmala Sitharaman in her Budget speech said the government would unveil as a Bio Pharma Shakti scheme with an outlay of Rs 10,000 crore over five years. The objective of the scheme is to support domestic innovation, research, and development (R&D) in biopharmaceuticals, specifically targeting treatments for diabetes, cancer, and auto-immune issues.
The BSE Healthcare index rose 370 pts to 41,717 in late morning deals against the previous close of 41,347.
Sun Pharma Advanced Research Co Ltd (SPARC) shares rose 10%, Syncom Formulations (India) Ltd (10%), Shilpa Medicare (14%) were among the top gainers on the BSE pharma index.
Budget 2026 LIVE Updates: Nirmala Sitharaman tables Union Budget 2026-27 in Lok Sabha, 
Vedanta, Hindustan Copper, Hindustan Zinc, SAIL, Tata Steel, JSW Steel shares tumble as Nifty Metal hits 10-month low
Union Budget 2026: Disinvestment seen as a key to fund capex push; execution risks persist
Defence stocks: MTAR Tech, Data Patterns, Ideaforge, BEL gain up to 7% as Budget 2026 gets Cabinet nod
Nvidia CEO Jensen Huang denies being 'unhappy' with OpenAI, plans to make 'huge investment'
Union Budget 2026: Why Defence Could Be The Key Focus This Time?
Union Budget 2026 | Modinomics 2026 | Budget Expectations, Tax Relief & India’s Economic Roadmap
Should India Worry About A Falling Rupee? Chief Economic Advisor Nageswaran Answers
Why Comfort And Style Define The Modern Golfer
Budget Hope In Varanasi Lanes: Can It Save The Fading Banarasi Handloom?
Budget 2026: Sensex jumps 416 pts, Nifty tops 25,400 as FM Sitharaman begins speechVedanta, Hindustan Copper, Hindustan Zinc, SAIL, Tata Steel, JSW Steel shares tumble as Nifty Metal hits 10-month lowDefence stocks: MTAR Tech, Data Patterns, Ideaforge, BEL gain up to 7% as Budget 2026 gets Cabinet nodUnion Budget 2026: Disinvestment seen as a key to fund capex push; execution risks persist
Budget 2026: Titan, Kalyan, Thangamayil, Golkunda shares fall up to 6%; here’s why